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Introduction
Research on biologically active compounds, such as 
plant phenolics, represents a big scientifi c challenge due 
to a great number of identifi ed substances, their chemical 
diversity as well as their huge biological potential, impor-
tant for the maintenance of healthy balance in our body. 
Undoubtedly, rosmarinic acid is one of the most studied 
phenolic compounds, exhibiting diﬀ erent biological ac-
tivities: antioxidant, anti-infl ammatory, antimutagenic, 
antibacterial, antiviral, cytotoxic on human breast cancer 
cells, neuroprotective in human neurons, and nephropro-
tective (1–8).
In plants, rosmarinic acid is formed from amino acids 
phenylalanine (caﬀ eic acid part of rosmarinic acid) and 
tyrosine (3,4-dihydroxyphenyllactic acid part) (9). It was 
isolated for the fi rst time from Rosmarinus oﬃ  cinalis and 
its structure was characterized as an ester of caﬀ eic acid 
and 3,4-dihydroxyphenyllactic acid (10,11). According to 
some authors (12,13), rosmarinic acid cannot be used as 
chemotaxonomic marker for diﬀ erentiation of plant fami-
lies due to its occurrence in various plant families such as 
Lamiaceae, Boraginaceae, Blechnaceae and Asteraceae. 
However, Lamiaceae species such as Satureja montana L., 
Thymus vulgaris L. and Origanum majorana L. are known 
as rich sources of rosmarinic acid (14–16).
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Summary
The present study compares the gastrointestinal stability of rosmarinic acid in aque-
ous extracts of thyme, winter savory and lemon balm with the stability of pure rosmarinic 
acid. The stability of rosmarinic acid was detected aft er two-phase in vitro digestion pro-
cess (gastric and duodenal) with human gastrointestinal enzymes. The concentration of 
rosmarinic acid in undigested and digested samples was detected using HPLC-DAD. Re-
sults showed that gastrointestinal stability of pure rosmarinic acid was signifi cantly higher 
than that of rosmarinic acid from plant extracts aft er both gastric and intestinal phases of 
digestion. Among plant extracts, rosmarinic acid was the most stable in lemon balm aft er 
gastric (14.10 %) and intestinal digestion phases (6.5 %). The temperature (37 °C) and slight-
ly alkaline medium (pH=7.5) did not aﬀ ect the stability of rosmarinic acid, while acid me-
dium (pH=2.5) signifi cantly decreased its stability (≥50 %). In addition, the stability rate of 
rosmarinic acid is infl uenced by the concentration of human gastrointestinal juices.
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The majority of published studies on rosmarinic acid 
are focused on methods of its detection in various plant 
extracts (17,18), its seasonal variations in selected plants 
(19) as well as its specifi c biological activity in diﬀ erent 
models (cell cultures, rats, in vitro methods) (5,8,20,21). 
Therefore, there is a lack of studies on the stability of ros-
marinic acid under gastrointestinal conditions using hu-
man gastrointestinal enzymes and on the infl uence of 
plant matrix on its stability rate. In that sense, in vitro 
models that mimic human physiology are recognized as 
simple, inexpensive and reproducible tools to study di-
gestive stability of compounds (22). In addition, in vitro 
digestion methods are generally based on the use of com-
mercial digestive enzymes, while studies with human 
gastrointestinal enzymes are still very rare.
Thus, the aim of this study is to determine the infl u-
ence of digestion phase (gastric and duodenal), tempera-
ture and pH on the stability of rosmarinic acid. In this 
study human gastrointestinal juices (gastric and duode-
nal) collected from healthy donors are used instead of 
commercial gastrointestinal enzymes. The stability rate of 
rosmarinic acid is measured by HPLC-DAD technique.
Materials and Methods
Plant material
Plant materials used in this study were dry leaves of 
Thymus vulgaris L. (thyme), Satureja montana L. (winter sa-
vory), and Origanum majorana L. (lemon balm). The above-
-mentioned samples are commercially available, in form 
of tea-like preparations, and were purchased from a local 
herbal pharmacy (Suban d.o.o., Strmec Samoborski, Croa-
tia). Pretreatment of the plant material included its ho-
mogenization using high speed grinder for 1 min.
Preparation of aqueous extracts
Pulverized plant materials (2.5 g) were extracted with 
distilled water (25 mL). To obtain bett er extraction yield, 
instead of conventional procedure, ultrasonic bath-assist-
ed extraction was used. Flasks with suspensions were im-
mersed in ultrasonic water bath heated to 50 °C. The ex-
traction time was 1 h. Aft er cooling, the samples were 
fi ltered and centrifuged for 5 min at 1800×g. The extrac-
tion of each sample was performed in triplicate. The ob-
tained extracts of the same plant species were combined 
into the fi nal extract that was used in further experiments.
Collection of human digestive juices
Human gastric and duodenal juices were collected 
from four donors (two male and two female) without 
known gastrointestinal pathology, and who were not tak-
ing acid secretion inhibitors or antibiotics. Gastric and 
duodenal juices were aspirated through the endoscope. 
Eight hours before the procedure, all liquid or food intake 
was ceased. For each patient, 3 mL of initially aspired 
juice were discarded and the remaining amount was col-
lected in a sterile tube, which was centrifuged to remove 
mucus and cell debris. In order to reduce interindividual 
variations, batches of pooled gastric and intestinal juices 
were prepared and then stored at –20 °C until use. The 
approval for the collection of digestive juices was ob-
tained from the Ethics Committ ee of the University Hos-
pital Centre Split, Croatia.
Determination of enzymatic activity of collected juices
The procedure described by Almaas et al. (23) was 
used to determine enzymatic activity of the prepared 
pooled human gastric juice samples. Pepsin activity was 
measured using 2.5 % solution of bovine haemoglobin. 
The solution was prepared in 0.2 M phosphate buﬀ er 
(pH=7.6) and then acidifi ed (to pH=3) using H2SO4. In or-
der to determine the human duodenal juice activity, ca-
sein solution (1 %) dissolved in 0.2 M phosphate buﬀ er 
(pH=7.6) was used. A volume of 500 μL of prepared pro-
tein solutions was incubated with 5, 20 or 50 μL of gastro-
intestinal juice. The digestion reactions were stopped 
with the addition of 1 mL of 10 % trichloroacetic acid 
(TCA). Samples were measured spectrophotometrically 
at 280 nm. One unit (U) of enzyme activity is defi ned as 
the amount of enzyme that causes the absorbance change 
of 1 between the blank and the sample, aft er 20 min at 
37 °C.
In vitro digestion process
A two-phase digestion procedure was performed ac-
cording to the method described by Furlund et al. (24). 
Gastric and intestinal digestion phases were performed at 
37 °C, in shaking bath (180 rpm). The volume of digestive 
juice corresponding to 1 U of enzymatic activity was 20 
μL of human gastric juice and 25 μL of human duodenal 
juice. Before in vitro digestion procedure, the concentra-
tion of rosmarinic acid in the prepared aqueous extracts 
from selected plants was normalized (471.48 mg/L). For 
digestion, 4 mL of aqueous extracts were used. The pH of 
the samples was adjusted to pH=2.5 using 1 M HCl for 
gastric phase, and to pH=7.5 using 2 M NaOH for intesti-
nal phase. The concentration of human juices used for 
this assay was 20 U per g of plant material for gastric and 
62.4 U per g of plant material for intestinal phase. In order 
to determine the infl uence of diﬀ erent concentrations of 
juices on the stability of rosmarinic acid, following con-
centrations were used: 5, 10, and 20 U per g of plant mate-
rial for gastric phase, and 15.6, 20, and 62.4 U per g of 
plant material for intestinal phase. The incubation period 
of gastric phase was 30 min, while aliquots of intestinal 
samples were collected aft er 60 and 120 min of intestinal 
phase. Enzymatic reactions were stopped on ice and the 
samples were stored at –20 °C until analyses. All diges-
tion processes were run in duplicate. Stability rate of ros-
marinic acid represents the ratio of its concentration before 
in vitro digestion and aft er gastric or intestinal digestion 
phases.
HPLC-DAD detection of rosmarinic acid
The rosmarinic acid was analyzed by a direct injec-
tion of the extracts, previously fi ltered through a 0.45-μm 
pore size membrane fi lter (Macherey-Nagel GmbH & Co. 
KG, Düren, Germany). Chromatographic separation was 
performed using HPLC instrument with Agilent 1260 
quaternary LC Infi nity system (Agilent Technologies, Santa 
Clara, CA, USA) equipped with diode array detector 
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(DAD), an automatic injector and ChemStation soft ware. 
The separation of compounds was performed on a Nu-
cleosil 100-5C18 (250 mm×4.6 mm, i.d. 5 μm) column (Ma-
cherey-Nagel GmbH & Co. KG). The solvent composition 
and the used gradient conditions were described previ-
ously by Generalić Mekinić et al. (13). For gradient elu-
tion, mobile phase A contained 2 % of acetic acid (T.T.T., 
Sveta Nedelja, Croatia) in water, while solution B con-
tained 2 % of acetic acid in acetonitrile (BDH Prolabo, 
VWR International, Lutt erworth, UK). The used elution 
program was as follows: from 0 to 3 min 2 % B, from 3 to 
25 min 30 % B, from 25 to 35 min 80 % B, and fi nally for 
the last 5 min again 0 % B. The fl ow rate was 1.0 mL/min 
and the injection volume was 24 μL. Detection was per-
formed with UV/Vis–photo diode array detector (Agilent 
Technologies) by scanning from 250 to 300 nm. Identifi ca-
tion of rosmarinic was carried out by comparing retention 
times and spectral data with those of the authentic stan-
dards at 280 nm. The quantifi cations of rosmarinic acid 
were made by the external standard method. Working 
rosmarinic acid standard solutions were prepared by di-
luting the stock solution to yield five concentrations in a 
range from 175 to 700 mg/L. Quantitative determination 
was carried out using the calibration curves of the stan-
dard (y=31.834x, R2=0.99). Quantitative determination was 
based on peak area from HPLC analyses and from the 
mass concentration of the compound. The results were 
expressed in mg per mL of extract, as mean value±stan-
dard deviation (N=2 replicates).
Statistical analysis
Statistical analysis was performed using GraphPad 
InStat3 soft ware (GraphPad Soft ware Inc., San Diego, CA, 
USA). The relationship between the obtained parameters 
was described using Pearson’s correlation coeﬃ  cient r. 
Diﬀ erences at p<0.05 were considered to be statistically 
signifi cant.
Results and Discussion
Lamiaceae species are known as a rich source of ros-
marinic acid (14–16). In this study, three diﬀ erent plants 
from the Lamiaceae family were used: Thymus vulgaris L., 
Origanum majorana L. and Satureja montana L. Prepared 
aqueous extracts contained diﬀ erent concentrations of 
rosmarinic acid, measured by HPLC-DAD (Fig. 1). There-
fore, before the two-step in vitro digestion, the concentra-
tion of rosmarinic acid was normalized in all prepared 
aqueous extracts so that the concentration measured in 
thyme (471.48 mg/L) was taken as primary concentration 
before in vitro digestion. Table 1 shows the concentration 
and the stability rate of rosmarinic acid in plant extracts 
in comparison with pure rosmarinic acid aft er the gastric 
digestion phase (pH=2.5). The duration of gastric phase 
was 30 min because liquids with a low protein concentra-
tion are considered to have very short transit time in the 
stomach (25). Rosmarinic acid was the most stable in 
Origanum majorana L. extract (14.10 %) in comparison 
with Satureja montana L. extract (5.8 %) and Thymus vul-
garis L. extract (0.8 %) aft er digestion phase. However, the 
stability rate of pure rosmarinic acid was signifi cantly 
higher (30.77 %) than in rosmarinic acid from plant mate-
rial. Incubation temperature (37 °C) did not aﬀ ect the sta-
bility of rosmarinic acid, which is in accordance with the 
results of other authors (26,27). On the other hand, the in-
cubation period of 30 min in the acidic medium (pH=2.5) 
decreased its concentration by more than 50 % (Table 1). 
The obtained results are not in accordance with those pre-
sented by Dinis et al. (28), who concluded that rosmarinic 
acid in Mentha species was stable at low pH under simu-
lated gastrointestinal conditions using commercial en-
zymes (pepsin and pancreatin). Contrary to commercial 
enzymes, human digestive juices consist of a variety of 
enzymes, inhibitors and bile salts that collectively con-
tribute to the digestion of food sample (29). In human 
gastric juices the following components have been detect-
ed: pepsin, trypsin, gastricsin, bile, small peptides and 
protein fragments (30). Duodenal juice contains pancre-
atic and intestinal enzymes such as proteolytic enzymes, 
intestinal lipases, enterokinase, trypsinogen, chymotryp-
sinogen, and amylase (31).
Results of the stability determination of rosmarinic 
acid aft er intestinal digestion phase are shown in Table 1. 
Aliquots of digested samples were collected aft er 60 and 
120 min of intestinal phase. Duration time of 120 min for 
intestinal phase was chosen according to in vivo results 
obtained by Troost et al. (32). The stability aft er intestinal 
digestion phase of pure rosmarinic acid diﬀ ers complete-
ly from the stability of rosmarinic acid in plant extracts 
(Table 1). In comparison with its primary concentration in 
plant extracts, rosmarinic acid was almost completely de-
graded aft er intestinal digestion phase. Aft er 120 min of 
intestinal digestion, the highest concentration was detect-
ed in Origanum majorana L. extract (30.8 mg/L). The ob-
tained results are not in line with the results by Dinis et al. 
(28), who reported that pancreatin (commercial mixture 
of amylase, lipase and protease) did not provoke the deg-
radation of rosmarinic acid in Mentha species. Also, Bel- 
-Rhild et al. (33) did not observe any hydrolysis of rosma-
rinic acid aft er the passage of rosemary extract through 
the gastrointestinal tract model (using commercial diges-
tive enzymes). Putative reasons for such discrepancies 
could be explained by two factors: the diﬀ erence in in vi-
tro digestion procedure between commercial digestive en-
zymes and human gastrointestinal enzymes, and the ma-
trix eﬀ ect – the rosmarinic acid can behave diﬀ erently in 
Mentha species and/or Rosmarinus oﬃ  cinalis extract in 
comparison with other plant species containing it. In con-
trast to rosmarinic acid in aqueous plant extracts, pure 
rosmarinic acid showed very high resistance to digestion 
by intestinal human juices (its stability rate was approx. 
78 % aft er 120 min of intestinal phase). In addition, ac-
cording to the results presented in Table 1, the degrada-
tion of rosmarinic acid aft er intestinal phase is not infl u-
enced by the pH. At pH=7.5 the rosmarinic acid is almost 
completely stable. Table 2 shows the infl uence of diﬀ erent 
concentrations of human gastric and duodenal juices on 
the stability of rosmarinic acid in the prepared aqueous 
extract from Satureja montana L. In order to investigate the 
infl uence of the concentration of human gastrointestinal 
juices, three diﬀ erent concentrations were tested: 5, 10 
and 20 U per g of plant material of gastric juices, and 15.6, 
20 and 62.4 U per g of plant material of duodenal juices. 
The obtained results showed that rosmarinic acid stability 
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depends on the concentration of human gastrointestinal 
juices (the lowest the concentration of digestive juice, the 
highest the stability of rosmarinic acid; Table 2).
Higher stability rate of rosmarinic acid aft er in vitro 
intestinal digestive phase may be also related to its ability 
to react with pancreatic enzymes that inhibit their activity 
Table 1. Concentrations and stability rates of rosmarinic acid in aqueous extracts of Thymus vulgaris L., Satureja montana L. and Origa-
num majorana L. aft er in vitro gastric and intestinal digestion 
Sample
Gastric digestion Intestinal digestion
t=30 min t=60 min t=120 min
γ/(mg/L) Stability/% γ/(mg/L) Stability/% γ/(mg/L) Stability/%
Thymus vulgaris     3.99±0.03   0.8±0.0   20.4±1.8   4.3±0.3     2.32±0.07   0.49±0.01
Satureja montana   27.5±0.0   5.8±0.0   17.7±0.2   3.75±0.03   15.9±0.2   3.81±0.05
Origanum majorana   66.5±0.2 14.10±0.02   29.10±0.09   6.17±0.01   30.8±4.2   6.5±0.6
Rosmarinic acid (control) 145.1±0.4 30.77±0.06 463.3±0.1 98.26±0.03 370.8±0.2 78.64±0.03
Rosmarinic acid (undigested)     (206.6±28.1)*   (43.81±0.03)* n.d. n.d.    (430.9±1.3)**    (91.4±0.2)**
*at pH=2.5, **at pH=7.5; n.d.=not detected
Concentration of human gastric juice was 20 U per g of plant material and of human duodendal juice 62.4 U per g of plant material. 
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Fig. 1. The investigated Lamiaceae species and their HPLC-DAD chromatograms with the signed peak of the dominant compound 
(rosmarinic acid) and its structure. The rosmarinic acid concentration in Satureja montana L., Origanum majorana L. and Thymus vul-
garis L. extracts was 1579.56, 821.06 and 471.48 mg/L, respectively. Photos taken from Wikimedia Commons database
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(34). It was reported that rosmarinic acid-derived qui-
nones react with amino acid side chains and free thiol 
groups of the enzyme (35). In addition, the interaction be-
tween phenolic acids and fl avonoids has been reported 
and the presence of some fl avonoids such as luteolin and 
apigenin enhances the stability rate of rosmarinic acid 
(36,37). According to the available data, the highest con-
tent of luteolin and apigenin among the three selected La-
miaceae plants was detected in Origanum majorana aque-
ous extracts, in which the rosmarinic acid stability was 
the highest aft er both, gastric and intestinal phases (38).
Conclusions
There is a lack of information about the gastrointesti-
nal stability of rosmarinic acid. Results of this study 
showed several interesting observations on digestive sta-
bility of rosmarinic acid using in vitro digestion with hu-
man gastrointestinal enzymes. The huge diﬀ erence was 
found in the stability of pure rosmarinic acid and rosma-
rinic acid in aqueous extracts from diﬀ erent plant materi-
al belonging to Lamiaceae family. Pure rosmarinic acid 
was more stable aft er duodenal phase (78.64 %) than dur-
ing gastric phase (30.77 %). Acid medium greatly reduced 
the stability of rosmarinic acid (>50 %), while the eﬀ ect of 
the incubation temperature and slightly alkaline medium 
were not signifi cant. There were diﬀ erences in the stabili-
ty of rosmarinic acid among diﬀ erent plant extracts. In 
our study, rosmarinic acid showed the highest stability af-
ter both digestive phases in Origanum majorana aqueous 
extract. In addition, the concentration of human gastroin-
testinal juices aﬀ ected the stability of rosmarinic acid in 
both digestive phases. Finally, the obtained results 
showed lower gastrointestinal stability of rosmarinic acid 
than in other studies using commercial digestive en-
zymes.
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